company background image
PHRM logo

PharmaTher Holdings CNSX:PHRM Stock Report

Last Price

CA$0.23

Market Cap

CA$19.9m

7D

4.7%

1Y

-28.6%

Updated

27 Dec, 2024

Data

Company Financials

PharmaTher Holdings Ltd.

CNSX:PHRM Stock Report

Market Cap: CA$19.9m

PHRM Stock Overview

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. More details

PHRM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Risk Analysis

Makes less than USD$1m in revenue (CA$0)

Has less than 1 year of cash runway

Earnings have declined by 40.8% per year over past 5 years

Does not have a meaningful market cap (CA$20M)

+ 1 more risk

My Notes

Capture your thoughts, links and company narrative

PharmaTher Holdings Ltd. Competitors

Chalice Brands

CNSX:CHAL

CA$19.0m

Charlotte's Web Holdings

TSX:CWEB

CA$22.1m

Rubicon Organics

TSXV:ROMJ

CA$26.9m

Antibe Therapeutics

TSX:ATE

CA$15.6m

Price History & Performance

Summary of share price highs, lows and changes for PharmaTher Holdings
Historical stock prices
Current Share PriceCA$0.23
52 Week HighCA$0.43
52 Week LowCA$0.17
Beta3.37
1 Month Change-13.46%
3 Month Change-10.00%
1 Year Change-28.57%
3 Year Change-32.84%
5 Year Changen/a
Change since IPO15.38%

Recent News & Updates

Recent updates

Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Shareholder Returns

PHRMCA PharmaceuticalsCA Market
7D4.7%1.2%1.0%
1Y-28.6%-30.7%15.9%

Return vs Industry: PHRM exceeded the Canadian Pharmaceuticals industry which returned -30.3% over the past year.

Return vs Market: PHRM underperformed the Canadian Market which returned 16.1% over the past year.

Price Volatility

Is PHRM's price volatile compared to industry and market?
PHRM volatility
PHRM Average Weekly Movement16.5%
Pharmaceuticals Industry Average Movement12.1%
Market Average Movement8.2%
10% most volatile stocks in CA Market17.3%
10% least volatile stocks in CA Market3.0%

Stable Share Price: PHRM's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: PHRM's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2019n/aFabio Chianelliwww.pharmather.com

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.

PharmaTher Holdings Ltd. Fundamentals Summary

How do PharmaTher Holdings's earnings and revenue compare to its market cap?
PHRM fundamental statistics
Market capCA$19.92m
Earnings (TTM)-CA$2.16m
Revenue (TTM)n/a

0.0x

P/S Ratio

-9.2x

P/E Ratio

Is PHRM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHRM income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$2.16m
Earnings-CA$2.16m

Last Reported Earnings

Aug 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.024
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PHRM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 06:02
End of Day Share Price 2024/12/24 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PharmaTher Holdings Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Patrick TrucchioH.C. Wainwright & Co.